Quick Answer
PDS Biotechnology Corp reported Total Assets of $30.49 million for fiscal year 2025.
PDS Biotechnology Corp Total Assets — Annual History
| Fiscal Year | Total Assets | YoY Change |
|---|---|---|
| 2025 | $30.49M | -32.8% |
| 2024 | $45.36M | -23.6% |
| 2023 | $59.39M | -22.9% |
| 2022 | $77.01M | +14.6% |
| 2021 | $67.20M | +117.5% |
| 2020 | $30.89M | +113.2% |
| 2019 | $14.49M | +8713.0% |
| 2018 | $164.4K | -99.8% |
| 2017 | $92.62M | -16.5% |
| 2016 | $110.91M | -17.3% |
| 2015 | $134.09M | +696.0% |
| 2014 | $16.85M | — |
Quarterly Total Assets
| Quarter Ending | Total Assets | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $34.71M | -33.8% | -14.3% |
| June 30, 2025 | $40.48M | -33.1% | -13.9% |
| March 31, 2025 | $47.03M | -31.8% | +3.7% |
| December 31, 2024 | $45.36M | -23.6% | -13.5% |
| September 30, 2024 | $52.45M | -8.3% | -13.3% |
| June 30, 2024 | $60.50M | -5.1% | -12.3% |
| March 31, 2024 | $69.01M | +0.8% | +16.2% |
| December 31, 2023 | $59.39M | -22.9% | +3.9% |
- PDS Biotechnology Corp showed a decrease of -32.8% in Total Assets compared to the prior fiscal year.
- Over the 2014–2025 period, PDS Biotechnology Corp’s total assets has grown by 81.0% (from $16.85 million to $30.49 million).
- The most recent figure is from PDS Biotechnology Corp’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 30, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: